1LZL

Bacterial Heroin Esterase

Summary for 1LZL

• Entry DOI: 10.2210/pdb1lzl/pdb
• Related: 1lzk
• Descriptor: HEROIN ESTERASE (2 entities in total)
• Functional Keywords: alpha/beta hydrolase, hydrolase
• Biological source: Rhodococcus sp.
• Total number of polymer chains: 1
• Total formula weight: 34309.62

Authors

Zhu, X.,Larsen, N.A.,Basran, A.,Bruce, N.C.,Wilson, I.A. (deposition date: 2002-06-10, release date: 2003-01-28, Last modification date: 2024-02-14)

Primary citation

ZHU, X.,LARSEN, N.A.,BASRAN, A.,BRUCE, N.C.,WILSON, I.A.
OBSERVATION OF AN ARSENIC ADDUCT IN AN ACETYL ESTERASE CRYSTAL STRUCTURE
J.Biol.Chem., 278:2008-2014, 2003

PubMed Abstract: The crystal structures of an acetyl esterase, HerE, and its complex with an inhibitor dimethylarsinic acid have been determined at 1.30- and 1.45-A resolution, respectively. Although the natural substrate for the enzyme is unknown, HerE hydrolyzes the acetyl groups from heroin to yield morphine and from phenyl acetate to yield phenol. Recently, the activity of the enzyme toward heroin has been exploited to develop a heroin biosensor, which affords higher sensitivity than other currently available detection methods. The crystal structure reveals a single domain with the canonical alpha/beta hydrolase fold with an acyl binding pocket that snugly accommodates the acetyl substituent of the substrate and three backbone amides that form a tripartite oxyanion hole. In addition, a covalent adduct was observed between the active site serine and dimethylarsinic acid, which inhibits the enzyme. This crystal structure provides the first example of an As-containing compound in a serine esterase active site and the first example of covalent modification of serine by arsenic. Thus, the HerE complex reveals the structural basis for the broad scope inhibition of serine hydrolases by As(V)-containing organic compounds.

PubMed: 12421810
DOI: 10.1074/jbc.M210103200

Experimental method

X-RAY DIFFRACTION (1.3 Å)